Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2019-11-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于第四届董事会第八次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the eighth meeting of the fourth board of directors of the company. It includes details about the meeting date, attendance, and voting results on specific proposals, such as changing the accounting firm and convening an extraordinary general meeting. It does not contain full financial statements or detailed financial performance data. It is a formal announcement related to board decisions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but an official announcement of board meeting resolutions.
2019-11-28 Chinese
独立董事关于公司变更会计师事务所的事前认可意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from independent directors regarding the company's change of accounting firm. It references regulatory guidelines and confirms the suitability of the new auditor for the 2019 audit. The document is short (555 characters) and does not contain any financial statements or audit results itself. It is not an audit report but rather an approval or opinion related to an audit-related corporate action. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance-related announcement rather than a full audit report or annual report.
2019-11-28 Chinese
关于变更会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the company's accounting firm for the 2019 fiscal year. It details the decision process, approvals by the board and supervisory committee, and the qualifications of the new auditor. There is no actual audit report or financial statements included, only the announcement of the change of auditor. The document length is relatively short (2650 characters) and it serves as a formal notice to shareholders and the public about the auditor change. Therefore, it is not an audit report itself but an announcement related to audit services. According to the classification rules, such announcements about auditor changes fall under Regulatory Filings (RNS) as they do not contain the audit report or financial data themselves.
2019-11-28 Chinese
关于公司获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about obtaining an invention patent certificate. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, no voting results, no management changes, no legal proceedings, no capital changes, and no other financial or governance report content. The document is an official company announcement about intellectual property rights, which does not fit into any specific financial report category. Given its nature and length (600 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous company announcements that do not fit other categories.
2019-11-25 Chinese
关于控股股东、实际控制人之一减持股份的公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding the reduction of shares held by a controlling shareholder and actual controller of the company. It details the number of shares sold, the method of sale, the shareholding percentages before and after the sale, and compliance with relevant securities laws and regulations. There is no financial data, earnings information, or management discussion of financial results. The content focuses on insider share transactions by a director or controlling shareholder. Therefore, this document fits the category of Director's Dealing (DIRS). The document length is 2341 characters, which is consistent with a detailed announcement but not a full financial report.
2019-11-14 Chinese
关于第四届董事会第七次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the seventh meeting of the fourth board of directors of the company. It specifically mentions the approval of the company's 2019 third quarter report and states that the report will be released externally on October 29, 2019. The document itself does not contain the financial data or the full report but is a notice about the board meeting decisions and the upcoming report release. The document length is short (746 characters), and it fits the pattern of a Regulatory Filing (RNS) as it is an official announcement related to corporate governance and report approval, not the report itself.
2019-10-28 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.